Muscle effects are the most common reported adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A inhibitors (statins). [Drugs prescribed to lower cholesterol levels in people with or at risk of cardiovascular disease.]
However, in placebo-controlled trials the incidence of muscle pain is most often similar for placebo and active control groups.
Objective: We sought to evaluate whether statin use was associated with a higher prevalence of musculoskeletal pain in a nationally representative sample.
Methods: Cross-sectional analysis using data from the National Health and Nutrition Examination Survey (NHANES) 1999-2002. Participants were 3,580 adults [age 40 or older] >/=40 years without arthritis who were interviewed at home and examined in a mobile examination center.
Participants were asked about sociodemographic characteristics, health conditions, medication use, and musculoskeletal pain. Height, weight, blood pressure, ankle brachial index, and cholesterol were measured.
Measurements and Main Results:
Prevalence and adjusted odds ratios (OR) of any musculoskeletal pain and musculoskeletal pain in 4 different anatomical regions (neck/upper back, upper extremities, lower back, and lower extremities) by statin use during the last 30 days.
Among statin users (n = 402), 22.0% (95%CI 18.0-26.7%) reported musculoskeletal pain in at least 1 anatomical region during the last 30 days, compared with 16.7% (95%CI 15.1-18.4%) of those who did not use a statin.
Compared to persons who did not use statins, those who used statins had multivariable-adjusted odds ratios (95%CI; p value) of:
1.50 (1.07-2.11; p = .01) for any musculoskeletal pain, [A 1.0 odds ratio would mean likelihood of pain in the statin and non-statin groups was equal; 1.50 means pain was significantly more likely in the statin group.]
1.59 (1.04-2.44, p = .03) for lower back pain,
And 1.50 (1.02-2.22, p = .03) for lower extremity pain.
Conclusion: Musculoskeletal pain is common in adults >/=40 years without arthritis. In this nationally representative sample, statin users were significantly more likely to report musculoskeletal pain.
Source: Journal of General Internal Medicine, May 2008 [E-pub ahead of print] PMID: 18449611, by Buettner C, Davis RB, Leveille SG, Mittleman MA, Mukamal KJ. Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. [E-mail: firstname.lastname@example.org]